Parkinsons Treatment Market Size, Share, Growth Report To 2030
The report "Parkinsons Treatment Market by Drug Class (Monoamine Oxidase Inhibitors (MAO), Dopamine Precursors, Catechol-o-methyltransferase Inhibitors (COMT), Peripheral Decarboxylase Inhibitors, Others (Anticholinergics, Antihistaminics)), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecasts to 2030" The global Parkinsons Treatment Market is projected to reach USD 4,482.4 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 12.4% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=16235 Competitive Dashboard: The prominent key players operating in the global Parkinsons Treatment Market are Salix Pharmaceuticals (U.S.) GlaxoSmithKline Plc. (U.K.) Wockhardt Limited (India) Impax Laboratories, Inc. (U.S) Novartis AG (Switzerland) Mylan N.V (U.S) Teva Pharmaceutical Industries Ltd. (Israel) Cipla Inc.(India) Par Pharmaceutical (U...